Welcome to LookChem.com Sign In|Join Free

CAS

  • or

349128-19-4

Post Buying Request

349128-19-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

349128-19-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 349128-19-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,9,1,2 and 8 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 349128-19:
(8*3)+(7*4)+(6*9)+(5*1)+(4*2)+(3*8)+(2*1)+(1*9)=154
154 % 10 = 4
So 349128-19-4 is a valid CAS Registry Number.

349128-19-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[4-(ethylaminosulfonyl)phenyl]acetamide

1.2 Other means of identification

Product number -
Other names Essigsaeure-(4-aethylsulfamoyl-anilid)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:349128-19-4 SDS

349128-19-4Relevant articles and documents

Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4

Li, Cong,Deng, Xiaobing,Zhang, Weilin,Xie, Xiaowen,Conrad, Marcus,Liu, Ying,Angeli, José Pedro Friedmann,Lai, Luhua

, p. 266 - 275 (2019/01/15)

Glutathione peroxidase 4 (GPX4) is essential for cell membrane repair, inflammation suppression, and ferroptosis inhibition. GPX4 upregulation provides unique drug discovery opportunities for inflammation and ferroptosis-related diseases. However, rationa

NOVEL ADENOSINE A3 RECEPTOR AGONISTS

-

Page/Page column 31, (2008/06/13)

The invention realizes that a series of sulfonamido derivatives with a conserved uronamide group at the 5' position provide superior A3 receptor affinity as well as selectivity. These new adenosine agonists are sulfonamido deritatives N-substituted with aliphatic groups (cyclic or linear) or aromatic radicals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 349128-19-4